Open AccessIntermediate dose cytarabine improves survival and relapse-free rate compared with standard-dose cytarabine as post-remission treatment for acute myeloid leukemia
Author(s) -
Ye Li,
Lingsu Gao,
Qianyao Cheng,
Feng Guo,
Liang He,
Tingting Yuan,
Mingqing Zhu,
Yi Ma,
Min Pan,
Xiandeng Chu,
Meiqi Ding,
Guohui Yu
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000024273
Subject(s) - cytarabine , medicine , myeloid leukemia , gastroenterology , leukemia , chemotherapy , retrospective cohort study , myeloid , surgery